Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

BerGenBio and Merck to evaluate BGB324 with Keytruda in NSCLC and breast cancer

pharmaceutical-technologyMarch 13, 2017

Tag: BGB324 , NSCLC

PharmaSources Customer Service